Your session is about to expire
← Back to Search
Influenza Virus Challenge for Flu
Study Summary
This trial is testing the smallest dose of influenza H10N7 virus that may cause an uncomplicated mild to moderate flu infection in healthy people.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I have a serious long-term health condition like heart or lung disease.I have a serious health condition like heart or lung disease, or I am immunocompromised.I am a woman following specific fertility and contraception guidelines and do not have HIV.I live with or am in close contact with high-risk individuals such as those over 65, under 5, or nursing home residents.I am between 18 and 50 years old.You have any abnormal results in your blood tests, urine tests, heart tests, lung tests, recent illnesses, allergies, recent vaccinations, drug or alcohol problems, mental health issues, recent contact with flu or COVID-19, complications from COVID-19 in the past, do not speak English, or any other health issues that could prevent you from taking part in the study.You are currently pregnant, trying to get pregnant, breastfeeding, have a very low or very high body weight, smoke or vape, have had facial reconstructive procedures, or have certain infections.I am following the required guidelines for contraception and fertility.
- Group 1: 1
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the regulatory agency given its approval to A/Mallard/Ohio-99/MM4/1989 H10N7?
"We assessed the safety of A/Mallard/Ohio-99/MM4/1989 H10N7 to be a 1 as there is restricted evidence in terms of both efficacy and safety, seeing as this is an initial Phase 1 trial."
How can I be considered for inclusion in this clinical experiment?
"This clinical trial seeks to enroll two hundred individuals of legal adulthood between 18 and 50 years old suffering from influenza. To be considered, candidates must adhere to the following conditions: have attained age eighteen or above (but below fifty) with no usage of tobacco products, marijuana, nor vaping; lack fertility in terms of a successful vasectomy or hysterectomy along with postmenopausal status; commit to maintaining abstinence and remain isolated for at least ten calendar days as well as comply with all study demands; consent to appropriate contraceptive methods such as implantable levonorgestrels or diaphragms when engaging in heterosexual intercourse alongside allowing"
Is the upper age limit for inclusion in this trial above 35 years?
"According to the requirements of this medical trial, potential enrollees must be between 18 and 50 years old."
Are there currently any open slots for potential participants in this trial?
"As indicated on clinicaltrials.gov, this medical trial is no longer recruiting patients for participation. Despite the initial posting taking place on December 7th 2022 and the most recent update being made on December 1st 2022, there are still 112 other trials that require volunteers at present."
Share this study with friends
Copy Link
Messenger